From: Scientific investigation of crude alkaloids from medicinal plants for the management of pain
Treatment/Dose | Licking time (Sec) | Inhibition (%) | ||
---|---|---|---|---|
1st Phase | 2nd Phase | 1st Phase | 2nd Phase | |
Control (2 % Tween 80) | 48.83 ± 1.627 | 72.83 ± 1.287 | ---- | ---- |
Wf Cr.A 50 mg | 22.35 ± 1.231*** | 20.12 ± 1.163*** | 54.22 | 72.37 |
Av Cr.A 50 mg | 28.31 ± 1.347** | 31.45 ± 1.342*** | 42.14 | 56.81 |
Ca Cr.A 50 mg | 34.75 ± 1.441* | 44.39 ± 1.568* | 28.68 | 39.04 |
Vn Cr.A 50 mg | 33.35 ± 1.604* | 38.93 ± 1.195** | 31.82 | 46.54 |
Ph Cr.A 50 mg | 24.85 ± 1.289*** | 24.53 ± 1.391*** | 49.16 | 66.31 |
Bp Cr.A 50 mg | 27.80 ± 1.468** | 33.79 ± 1.416** | 43.09 | 53.60 |
Indomethacin (10 mg) | 39.83 ± 1.541 | 18.66 ± 1.542*** | 18.43 | 74.37 |
Morphine (5 mg) | 6.416 ± 1.165*** | 2.83 ± 1.260*** | 86.86 | 96.11 |